Clinical trial
A Maximal Use Trial of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
NCT07049575 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Maximal Use Trial of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
- Lead sponsor
- Incyte Corporation
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- November 3, 2025
- Completion date
- December 9, 2026
- Enrollment
- 24 (estimated)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.